ESID Registry – Working Definitions for Clinical Diagnosis of PID

ESID Registry – Working Definitions for Clinical Diagnosis of PID

ESID Registry – Working Definitions for Clinical Diagnosis of PID These criteria are only for patients with no genetic diagnosis*. *Exceptions: Atypical SCID, DiGeorge syndrome – a known genetic defect and confirmation of criteria is mandatory Available entries (Please click on an entry to see the criteria.) Page Agammaglobulinaemia ................................................................................................................................................................ 4 Asplenia syndrome (Ivemark syndrome) ................................................................................................................................... 4 Ataxia telangiectasia (ATM) ......................................................................................................................................................... 4 Autoimmune lymphoproliferative syndrome (ALPS) ................................................................................................................ 4 APECED / APS1 with CMC - Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) .................. 5 Barth syndrome ............................................................................................................................................................................ 5 Bloom syndrome .......................................................................................................................................................................... 6 Cartilage hair hypoplasia (CHH) .................................................................................................................................................. 6 Chronic mucocutaneous candidiasis (CMC) ............................................................................................................................. 7 Complement component 2 deficiency ........................................................................................................................................ 7 Complement component 3 deficiency (C3) ................................................................................................................................ 7 CSR defects and HIGM syndromes ............................................................................................................................................. 8 Chediak Higashi syndrome (CHS) ............................................................................................................................................... 8 Chronic granulomatous disease (CGD) ...................................................................................................................................... 9 Clericuzio-type poikiloderma with neutropenia syndrome ....................................................................................................... 9 COHEN syndrome ........................................................................................................................................................................ 9 Combined immunodeficiency (CID) .......................................................................................................................................... 10 Common variable immunodeficiency disorders (CVID) .......................................................................................................... 10 Congenital neutropenia ............................................................................................................................................................. 11 Cyclic neutropenia ..................................................................................................................................................................... 11 Defects of TLR/NFkappa-B signalling ....................................................................................................................................... 11 Defects with susceptibility to mycobacterial infection (MSMD) ............................................................................................. 11 Deficiency of specific IgG (Specific antibody deficiency - SPAD) ......................................................................................... 12 DiGeorge syndrome ................................................................................................................................................................... 12 Dyskeratosis congenita ............................................................................................................................................................. 12 Factor D deficiency .................................................................................................................................................................... 12 Familial hemophagocytic lymphohistiocytosis syndromes (FHLH) ...................................................................................... 13 FOXP3 deficiency (IPEX) ............................................................................................................................................................ 13 Glycogen storage disease type 1b (GS1b) ............................................................................................................................... 13 ESID Registry - Working definitions for clinical diagnosis of PID July 18, 2016 page 1 of 25 Griscelli syndrome type 2 .......................................................................................................................................................... 14 Hereditary Angioedema (C1inh) ................................................................................................................................................ 14 Hermansky-Pudlak syndrome (type 2) ..................................................................................................................................... 14 HLA class I deficiency ................................................................................................................................................................ 15 HLA class II deficiency (MHC2) ................................................................................................................................................. 15 Hoyeraal-Hreidarsson syndrome .............................................................................................................................................. 15 Hyper IgE syndrome (HIES) ....................................................................................................................................................... 16 IgA with IgG subclass deficiency .............................................................................................................................................. 16 Immunodeficiency centromeric instability facial anomalies syndrome (ICF) ....................................................................... 16 IPEX-like disease ........................................................................................................................................................................ 17 Isolated IgG subclass deficiency .............................................................................................................................................. 17 Isolated congenital asplenia ...................................................................................................................................................... 17 Mannose-binding lectin deficiency (MBL) ................................................................................................................................ 17 Nijmegen breakage syndrome .................................................................................................................................................. 18 Omenn syndrome ....................................................................................................................................................................... 18 Partial albinism and immunodeficiency syndrome ................................................................................................................. 19 Properdin P factor complement deficiency (PFC) ................................................................................................................... 19 Schimke disease......................................................................................................................................................................... 19 Seckel syndrome ........................................................................................................................................................................ 20 Selective CD4 cell deficiency .................................................................................................................................................... 20 Selective IgA deficiency ............................................................................................................................................................. 20 Selective IgM deficiency ............................................................................................................................................................ 21 Severe combined immunodeficiency (SCID) ........................................................................................................................... 21 Shwachman-Diamond-syndrome .............................................................................................................................................

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    25 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us